Clinical features in patients with COVID-19 treated with biologics for severe asthma-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Clinical features in patients with COVID-19 treated with biologics for severe asthma

Published:2024-05 Issue:2 Volume:3 Page:100219
ISSN:2772-8293
Container-title:Journal of Allergy and Clinical Immunology: Global
language:en
Short-container-title:Journal of Allergy and Clinical Immunology: Global

Author:

Numata Takanori^ORCID,Okuda Keitaro,Miyagawa Hanae,Minagawa Shunsuke,Ishikawa Takeo,Hara Hiromichi,Araya Jun

Publisher

Elsevier BV

Reference28 articles.

1. Risk factors for severity on admission and the disease progression during hospitalisation in a large cohort of patients with COVID-19 in Japan;Terada;BMJ Open,2021

2. Does asthma affect morbidity or severity of COVID-19?;Matsumoto;J Allergy Clin Immunol,2020

3. Clinical characteristics of 140 patients infected with SARS-CoV-2 in Wuhan, China;Zhang;Allergy,2020

4. Distinct effects of asthma and COPD comorbidity on disease expression and outcome in patients with COVID-19;Song;Allergy,2021

5. Impact of anti-type 2 inflammation biologic therapy on COVID-19 clinical course and outcome;Poddighe;J Inflamm Res,2021

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP